09/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

09/2024

Sep 26, 2024, 15:11 | Blog
Caterina Sposetti: Supervised aerobic exercise in Early Breast Cancer undergoing (neo)adjuvant chemotherapy
Caterina Sposetti shared on X: "Hot off the press article by Neil Iyengar et al.…
Sep 26, 2024, 15:10 | Blog
Robin Zon: Thank you to TxSCO for inviting me to share ASCO's state of the union
Robin Zon shared a post on X: ''Thank you to Texas Society of Clinical Oncology for…
Sep 26, 2024, 15:08 | Blog
Mukhtasar Malcolm Alkali: Honored to meet Dan Milner at WCC
Mukhtasar Malcolm Alkali, Cancer Advocate at Medicaid Cancer Foundation, shared a post on X: ''We…
Sep 26, 2024, 15:05 | Blog
Jill Johnson: Mays Cancer Center is seeking adults receiving treatment for blood cancer to enroll in a remote study
Jill Johnson shared a post on X: ''Mays Cancer Center is seeking adults receiving treatment…
Sep 26, 2024, 15:04 | Insight
Stephanie Graff: Ever wondered what 'clinically meaningful' really means
Stephanie Graff shared a post on X: "Ever wondered what 'clinically meaningful' really means? We sought…
Sep 26, 2024, 14:52 | Blog
Carmen Uscatu: Cancer isn’t fair but care should be
Carmen Uscatu, Founding Member, President at Give Life (Dăruiește Viață), shared on LinkedIn: "Reflection of this…
Sep 26, 2024, 14:52 | Blog
OncoInfluencers to Follow on Social Media: Dr. Bhawna Sirohi
We are thrilled to feature Dr. Bhawna Sirohi as a leading figure in the oncology…
Sep 26, 2024, 14:37 | Insight
CCTG NE2 STOPNET Neuroendocrine Study Officially Opens in Canada
The CCTG NE2 STOPNET Study: Exploring the Role of Somatostatin Analogues in Neuroendocrine Tumor Treatment…
Sep 26, 2024, 14:34 | Blog
Yakup Ergun: Survival and recurrence rates following SBRT or surgery in operable Stage I NSCLC
Yakup Ergun, Medical Oncologist at Antalya City Hospital, shared a post on X, about recent…
Sep 26, 2024, 14:27 | Blog
Mehdi Hamadani: Efficacy of axatilimab in chronic graft-versus-host disease
Mehdi Hamadani shared a post on X, about recent paper published in The New England…
All: 2508 Posts: 361 - 370
Special Coverage